sb 203580 has been researched along with Endometriosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, M; Chao, Y; Chen, Z; Guan, Y; Guo, R; Li, X; Lin, C; Wang, Y; Wu, A; Xie, F; Yue, Y; Zhang, C | 1 |
Chen, QH; Chen, QX; Zhou, WD | 1 |
Chen, QH; Chen, QX; Liu, FA; Su, DY; Wang, Q; Yang, HM; Zhao, M; Zhou, WD | 1 |
1 review(s) available for sb 203580 and Endometriosis
Article | Year |
---|---|
[The action of p38 MAP kinase and its inhibitors on endometriosis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Endometriosis; Enzyme Inhibitors; Female; Humans; Imidazoles; Inflammation; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha | 2010 |
2 other study(ies) available for sb 203580 and Endometriosis
Article | Year |
---|---|
Activation of p38 MAPK in the rostral ventromedial medulla by visceral noxious inputs transmitted via the dorsal columns may contribute to pelvic organ cross-sensitization in rats with endometriosis.
Topics: Adipose Tissue; Animals; Colon; Disease Models, Animal; Endometriosis; Female; Imidazoles; Medulla Oblongata; p38 Mitogen-Activated Protein Kinases; Pain Threshold; Phosphorylation; Physical Stimulation; Pressure; Protein Kinase Inhibitors; Pyridines; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Transplantation, Autologous; Uterus; Visceral Pain | 2015 |
SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
Topics: Animals; Cytokines; Down-Regulation; Endometriosis; Female; Imidazoles; Interleukin-1beta; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Pyridines; Tumor Necrosis Factor-alpha | 2010 |